GOOD

The World’s First Malaria Vaccine Is Almost Here, and Will Be Entirely Not-For-Profit

Makers of the “Mosquirix” inoculations promise that any money earned will go solely to making the drug even more effective.

image via (cc) flickr user john tann

An estimated two hundred million people are infected with the malaria parasite annually. Hundreds of thousands of those infected are eventually killed by the disease, making its mosquito carriers the deadliest animals on earth. It is disproportionately fatal to children, and has long been the scourge of medics and health care workers, as well as economists, who estimate the total costs associated with the ongoing fight against the disease to be in the billions.


Thankfully, its days may soon be numbered.

This past week, pharmaceutical company GlaxoSmithKline announced that their experimental vaccine Mosquirix (also known as RTS,S) has been green-lit by the European Medicines Agency, thereby clearing a major hurdle on the drug’s way of being put into use. GSK claims theirs is the first malaria vaccine to have ever reached this milestone. And while Mosquirix still faces World Health Organization approval before it can be applied across infected regions, the drug is already being discussed as a monumental achievement in the fight against a devastating disease. Speaking with Reuters, GSK scientist Joe Cohen did not mince words: “I have absolutely no reservations in terms of rolling this vaccine out. Why? Because the efficacy, when translated into cases averted and deaths averted, is just tremendous. It will have an enormously significant public health impact.”

Mosquirix is the product of decades of research done in partnership between GSK and the PATH Malaria Vaccine Initiative, with funding provided in part by the Bill and Melinda Gates foundation, reports the BBC. The drug is designed specifically to fight malaria’s parasitic infection in children. Per a release from GSK, the drug was shown to have reduced cases of the disease by anywhere from 25 to over 50 percent, depending on the age of the child at the time of their first injection and subsequent booster shots.

image via (cc) flickr user usarmyafrica

Perhaps just as exciting as the prospect of finally having an inoculative method to prevent, and not just simply treat, malaria is GSK’s pledge that Mosquirix will be entirely non-profit. Instead, the injections will be priced at production cost plus a small mark-up, which will be used to fund research toward more effective iterations of the drug. Sources for Reuters predict this will likely cost in the neighborhood of $5 per injection, in a series of four.

Next, the drug’s makers must submit a series proposals to the World Health Organization. Should the WHO approve the treatment, the door would then be open for GSK to approach individual countries in regards to incorporating the vaccine into their malaria treatment programs. Explains GSK CEO Sir Andrew Witty:

Today’s scientific opinion represents a further important step towards making available for young children the world's first malaria vaccine. While RTS,S on its own is not the complete answer to malaria, its use alongside those interventions currently available such as bed nets and insecticides, would provide a very meaningful contribution to controlling the impact of malaria on children in those African communities that need it the most. The work doesn’t stop here and GSK remains committed to investing in R&D for malaria vaccines and treatments to find more ways to tackle this devastating disease.

So while a fully effective vaccine is still likely a ways away, today we are closer than ever to finally curbing the spread of malaria, once and for all.

****UPDATE***

An earlier version of this post mistakenly labled Malaria as a virus, and not a parasite.

[via goodnewsnetwork]

Articles
via Real Time with Bill Maher / YouTube and The Late Late Show with James Corden / YouTube

A controversial editorial on America's obesity epidemic and healthcare by comedian Bill Maher on his HBO show "Real Time" inspired a thoughtful, and funny, response by James Cordon. It also made for a great debate about healthcare that Americans are avoiding.

At the end of the September 6th episode of "Real Time, " Maher turned to the camera for his usual editorial and discussed how obesity is a huge part of the healthcare debate that no one is having.

"At Next Thursday's debate, one of the candidates has to say, 'The problem with our healthcare system is Americans eat shit and too much of it.' All the candidates will mention their health plans but no one will bring up the key factor: the citizens don't lift a finger to help," Maher said sternly.

Keep Reading Show less
Politics

There is no shortage of proposals from the, um, what's the word for it… huge, group of Democratic presidential candidates this year. But one may stand out from the pack as being not just bold but also necessary; during a CNN town hall about climate change Andrew Yang proposed a "green amendment" to the constitution.

Keep Reading Show less
test
Me Too Kit

The creator of the Me Too kit — an at home rape kit that has yet to hit the market — has come under fire as sexual assault advocates argue the kit is dangerous and misleading for women.

The kit is marketed as "the first ever at home kit for commercial use," according to the company's website. "Your experience. Your kit. Your story. Your life. Your choice. Every survivor has a story, every survivor has a voice." Customers will soon be able order one of the DIY kits in order to collect evidence "within the confines of the survivor's chosen place of safety" after an assault.

"With MeToo Kit, we are able to collect DNA samples and other tissues, which upon testing can provide the necessary time-sensitive evidence required in a court of law to identify a sexual predator's involvement with sexual assault," according to the website.

Keep Reading Show less
Health

Villagers rejoice as they receive the first vaccines ever delivered via drone in the Congo

The area's topography makes transporting medicines a treacherous task.

Photo by Henry Sempangi Senyule

When we discuss barriers to healthcare in the developed world, affordability is commonly the biggest concern. But for some in the developing world, physical distance and topography can be the difference between life and death.

Widjifake, a hard-to-reach village in northwestern Democratic Republic of Congo (DRC) with a population of 6,500, struggles with having consistent access to healthcare supplies due to the Congo River and its winding tributaries.

It can take up to three hours for vehicles carrying supplies to reach the village.

Keep Reading Show less
Health
via Keith Boykin / Twitter

Fox News and President Trump seem like they may be headed for a breakup. "Fox is a lot different than it used to be," Trump told reporters in August after one of the network's polls found him trailing for Democrats in the 2020 election.

"There's something going on at Fox, I'll tell you right now. And I'm not happy with it," he continued.

Some Fox anchors have hit back at the president over his criticisms. "Well, first of all, Mr. President, we don't work for you," Neil Cavuto said on the air. "I don't work for you. My job is to cover you, not fawn over you or rip you, just report on you."

Keep Reading Show less
Politics